Circulating Cell-Free Mitochondrial DNA as a Novel Biomarker for Intra-Amniotic Infection in Obstetrics: A Pilot Trial
Open Access
- 7 August 2024
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (16) , 4616
Abstract
Background/Objectives: Intra-amniotic infection (IAI) is a rare but serious condition with potential complications such as preterm labor and intrauterine fetal death. Diagnosing IAI is challenging due to varied clinical signs. Oxidative stress and mitochondrial dysfunction have been hypothesized to evolve around IAI. This study focused on measuring circulating mtDNA levels, a proposed biomarker for mitochondrial dysfunction, in maternal serum and placenta of women with confirmed IAI and healthy controls. Methods: 12 women with confirmed IAI (IAI group) were enrolled following premature preterm rupture of the membranes (PPROM) and compared to 21 healthy women (control group). Maternal blood was obtained two weeks pre-partum and peripartum; furthermore, postpartum placental blood was taken. In the IAI group, maternal blood was taken once weekly until delivery as well as peripartum, as was placental blood. Circulating cell-free mtDNA was quantified by real-time quantitative PCR. Results: Upon admission, in the IAI group, mean plasma mtDNA levels were 735.8 fg/μL compared to 134.0 fg/μL in the control group (p < 0.05). After delivery, in the IAI group, mean mtDNA levels in the placenta were 3010 fg/μL versus 652.4 fg/μL (p < 0.05). Conclusions: Circulating cell-free mtDNA could serve as a valuable biomarker for IAI prediction and diagnosis. Future research should establish reference values for sensitivity in predicting IAI.Keywords
All Related Versions
Funding Information
- The Medical–Scientific Fund of the Mayor of Vienna (Vienna, Austria) (18080)
This publication has 24 references indexed in Scilit:
- Role of leucocyte caspase-1 activity in epidural-related maternal fever: a single-centre, observational, mechanistic cohort studyBritish Journal of Anaesthesia, 2019
- Maternal serum mitochondrial DNA (mtDNA) levels are elevated in preeclampsia – A matched case-control studyPregnancy Hypertension, 2018
- Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significanceAmerican Journal of Obstetrics and Gynecology, 2015
- Is mitochondrial DNA content a potential biomarker of mitochondrial dysfunction?Mitochondrion, 2013
- Mitochondrial DNA as a non-invasive biomarker: Accurate quantification using real time quantitative PCR without co-amplification of pseudogenes and dilution biasBiochemical and Biophysical Research Communications, 2011
- Mitochondrial DNA and inflammatory diseasesHuman Genetics, 2011
- Maternal blood mitochondrial DNA content during normal and intrauterine growth restricted (IUGR) pregnancyAmerican Journal of Obstetrics and Gynecology, 2010
- Chorioamnionitis with a fetal inflammatory response is associated with higher neonatal mortality, morbidity, and resource use than chorioamnionitis displaying a maternal inflammatory response onlyAmerican Journal of Obstetrics and Gynecology, 2005
- Chorioamnionitis increases neonatal morbidity in pregnancies complicated by preterm premature rupture of membranesAmerican Journal of Obstetrics and Gynecology, 2005
- The maternal-fetal medicine units cesarean registry: chorioamnionitis at term and its duration—relationship to outcomesAmerican Journal of Obstetrics and Gynecology, 2004